Home / Share Price Target / Trabi
Transgene Biotek Share Price Target 2024, 2025, 2026 to 2039 With Charts
Transgene Biotek Limited | |||
 | Symbol: TRABI | ||
| Price: ₹6.5 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Transgene Biotek Financial Performance
- 0.1.1: Is Transgene Biotek A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Transgene Biotek Share Price Target For 2024
- 1.1.1: Transgene Biotek Share Price Target Table For 2024
- 1.1.2: Summary: Transgene Biotek Share Price Prediction For 2024
- 1.2: Transgene Biotek Share Price Target For 2025
- 1.2.1: Transgene Biotek Share Price Target Table For 2025
- 1.2.2: Summary: Transgene Biotek Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Transgene Biotek Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Transgene Biotek Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Transgene Biotek Past Performance
Transgene Biotek Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 48.18 Crore | Market valuation of Transgene Biotek's shares. |
| Revenue (TTM) | 5.5 Lakh | Total revenue generated by Transgene Biotek over the past twelve months. |
| Net Income (TTM) | -6 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -9775.96% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -20.39% | Net income as a percentage of revenue, after all expenses. |
| Debt-to-Equity (D/E) Ratio | 1.22 | Company's total debt divided by total shareholder equity. |
| Total Debt | 13.56 Crore | Sum of Transgene Biotek's current & long-term financial obligations. |
Is Transgene Biotek A Good Buy For Long Term?
Due to its low market capitalization, negative profit margin, and significant debt, Transgene Biotek is not a recommended buy at present. Its recent negative returns and low revenue generation further support this view.
To predict the Transgene Biotek's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Transgene Biotek Share Price Target For 2024
The line chart displays the monthly closing prices of Transgene Biotek with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Transgene Biotek shares in 2024, see the table below.
Transgene Biotek Share Price Target Table For 2024
| Transgene Biotek's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 6.79 (+4.46%) | Custom Fibonacci Extension Lvl 64.9% |
| 2024 Target 2 | 6.70 (+3.07%) | Price Action: 14 Nov 2024 Low |
| 2024 Target 1 | 6.60 (+1.53%) | Price Action: 24 Oct 2024 Low |
| Current Price | 6.50 | Transgene Biotek's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 6.46 (-0.62%) | Price Action: 06 Nov 2024 Low |
| Stop Loss 2 | 6.32 (-2.77%) | Price Action: 29 Oct 2024 Low |
| Stop Loss 3 | 6.25 (-3.85%) | Price Action: Apr 2014 High |
Summary: Transgene Biotek Share Price Prediction For 2024
In summary, Transgene Biotek has declined by ₹-3.37, recording a notable -34.14% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Transgene Biotek for 2024 predicts an additional rise of 1.53% to 4.46% by the end of 2024 with three potential targets T1: 6.60, T2: 6.70, T3: 6.79. Stop Loss at SL1: 6.46, SL2: 6.32, SL3: 6.25.
Transgene Biotek has a 52-week high of ₹12.46, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹5.79, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Transgene Biotek.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Transgene Biotek Share Price Target For 2025
The line chart displays the monthly closing prices of Transgene Biotek with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Transgene Biotek shares in 2025, see the table below.
Transgene Biotek Share Price Target Table For 2025
| Transgene Biotek's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 12.46 (+91.69%) | Fibonacci Extension Level 100% |
| 2025 Target 2 | 12.21 (+87.84%) | Price Action: Chart |
| 2025 Target 1 | 12.09 (+86%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 6.50 | Transgene Biotek's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 5.14 (-20.93%) | Price Action: Chart |
| Stop Loss 2 | 5.09 (-21.7%) | Price Action: Chart |
| Stop Loss 3 | 5.00 (-23.08%) | Price Action: Chart |
Summary: Transgene Biotek Share Price Prediction For 2025
In summary, Transgene Biotek has declined by ₹-3.37, recording a notable -34.14% decrease from 1st January 2024 to 21 Nov 2024. Despite the setback, our analysis of Transgene Biotek for 2025 predicts an additional rise of 86% to 91.69% by the end of 2025 with three potential targets T1: 12.09, T2: 12.21, T3: 12.46. Stop Loss at SL1: 5.14, SL2: 5.09, SL3: 5.00.
Transgene Biotek has a All-Time high of ₹322.50, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹5.79, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Transgene Biotek, we have created a specific page for that check here: Transgene Biotek Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Transgene Biotek Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Transgene Biotek share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 37.79% over the next 15 years.
For complete year by year Transgene Biotek long term share price target from 2024, 2025 to 2039 check the below table.
Transgene Biotek Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Transgene Biotek Target | YoY Change % |
|---|---|---|
| 2024 | ₹6.5 | [Current Price] |
| 2024 | ₹37.4 | 475.53% |
| 2025 | ₹11.39 | -69.56% |
| 2026 | ₹31.04 | 172.51% |
| 2027 | ₹60.14 | 93.75% |
| 2028 | ₹119.45 | 98.61% |
| 2029 | ₹150.11 | 25.66% |
| 2030 | ₹32.82 | -78.14% |
| 2031 | ₹73.45 | 123.82% |
| 2032 | ₹124.67 | 69.71% |
| 2033 | ₹224.99 | 80.46% |
| 2034 | ₹262.81 | 16.8% |
| 2035 | ₹54.25 | -79.36% |
| 2036 | ₹115.87 | 113.58% |
| 2037 | ₹189.21 | 63.29% |
| 2038 | ₹330.52 | 74.68% |
| 2039 | ₹3,326.7 | 906.5% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Transgene Biotek Past Performance
- In 2001, Transgene Biotek opening price was ₹7.5
- As of Thu 21 Nov 2024 the price stands at ₹6.5.
- This represents a Compound Annual Growth Rate (CAGR) of -0.59%.
- In 23 years, an investment of 10,000 would have become ₹8,666.66.
As we wrap up, we hope you like our study on Transgene Biotek share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
